EVAX NASDAQ
Evaxion Biotech A/S
1W: -4.2%
1M: +4.2%
3M: -5.3%
YTD: -32.1%
1Y: -27.9%
3Y: -92.4%
5Y: -99.3%
$3.20
+0.02 (+0.63%)
Weekly Expected Move ±5.9%
$3
$3
$3
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$28M
+127.5% ▲
5Y CAGR: +18.9%
Total Liabilities
$11M
-19.6% ▼
5Y CAGR: +18.2%
Shareholders Equity
$17M
+1131.4% ▲
5Y CAGR: +19.3%
Cash & Investments
$23M
+359.9% ▲
5Y CAGR: +31.8%
Total Debt
$8M
-25.7% ▼
5Y CAGR: +227.2%
Net Debt
-$16M
-411.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $32M | $13M | $6M | $5M | $23M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $32M | $13M | $6M | $5M | $23M |
| Net Receivables | $0 | $0 | $0 | $2M | $1M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $2M | $1M | $1M | $900K | $0 |
| Total Current Assets | $35M | $17M | $8M | $9M | $25M |
| Property, Plant & Equip. | $5M | $5M | $4M | $4M | $3M |
| Goodwill & Intangibles | $93K | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $44K | $0 |
| Other Non-Current Assets | $191K | $365K | $196K | $162K | $185K |
| Total Non-Current Assets | $5M | $5M | $5M | $4M | $4M |
| Total Assets | $40M | $22M | $13M | $12M | $28M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $2M | $3M | $3M | $2M |
| Short-Term Debt | $126K | $136K | $159K | $159K | $550K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $46K | $885K | $3M | $927K | $416K |
| Total Current Liabilities | $4M | $4M | $7M | $4M | $4M |
| Long-Term Debt | $1M | $8M | $8M | $8M | $5M |
| Other Non-Current Liab. | $153K | $144K | $149K | $141K | $158K |
| Total Non-Current Liabilities | $3M | $10M | $11M | $10M | $7M |
| Total Liabilities | $8M | $14M | $18M | $14M | $11M |
| — Equity — | |||||
| Common Stock | $4M | $4M | $6M | $11M | $16M |
| Retained Earnings | -$50M | -$86M | -$108M | -$119M | -$126M |
| Accumulated OCI | -$1M | $10M | $10M | -$4M | $7M |
| Total Stockholders Equity | $32M | $8M | -$5M | -$2M | $17M |
| Total Liabilities & Equity | $40M | $22M | $13M | $12M | $28M |
| — Key Metrics — | |||||
| Total Debt | $4M | $10M | $11M | $10M | $8M |
| Net Debt | -$28M | -$3M | $5M | $5M | -$16M |
| Total Investments | $0 | $0 | $0 | $44K | $0 |